The vestibular schwannoma therapeutic sector represents one of the most dynamic areas within rare neurological disorder management, driven by groundbreaking scientific discoveries and unprecedented pharmaceutical investment. These acoustic neuromas, while benign in nature, create substantial clinical challenges that have historically limited treatment options to invasive procedures with significant functional consequences. Market Intelligence and Commercial Opportunities Read.